Methyl BCD alters cell envelop studied by AFM
To elucidate the involvement of the cell envelope in the stiffness of sickle cells, methyl-β-cyclodextrin (MβCD), a putative cholesterol-depleting reagent
A forum for researchers, students and applicants in the field of cyclodextrin technology
To elucidate the involvement of the cell envelope in the stiffness of sickle cells, methyl-β-cyclodextrin (MβCD), a putative cholesterol-depleting reagent
RENATUS, a South Korea-based pharma company pioneering next generation cyclodextrin-based therapies for the safe treatment of cholesterol-associated diseases recently filed
US patent application US2022409653 entitled “METHOD FOR PREVENTING ENTRY AND REPLICATION OF ENVELOPED VIRUSES” descibes a method for the reduction
Recently the Francesco Trotta’s group of the University of Turin (Italy) has finalized and published the preliminar results that he
Li-Huei Tsai, director of Picower Institute for Learning and Memory (Massachusetts Institute of Technology) and her coworkers recently filed a patent
Cyclolab Ltd filed a patent application (US20220282001) on cyclodextrin containing physical mixtures and inclusion complexes that show improved protein stabilizing
After NASA’s Mars Curiosity rover and ESA’s Rosetta’s lander, Philae, traces of life on another extraterrestial object is expected to
The considerable increase in of anticancer and antimicrobial drug resistance in the last years have created a difficult situation in
The usual thinking with cyclodextrin is about its capacity to complex small molecules, even there is a considerable bibliography about
The researchers of College of Medicine (Pennsylvania) and Iowa University have published on ‘Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol